Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amlodipine versus bisoprolol in hypertensive patients with end-stage renal disease on maintenance hemodialysis
PACTR201909547623017Completed
- Sponsor
- Ahmed Youssef
- Start
- Aug 2019
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Trial of amlodipine and bisoprolol in hypertension (HTN) (2 arms), sponsored by Ahmed Youssef. Primary endpoint: Change from baseline to 6 months in left ventricular mass index. Started Aug 2019; status: completed.
02
Drugs
amlodipinebisoprolol
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on PACTR201909547623017.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201909547623017.